Back to search

United Kingdom· GB-APID-797011000001102

Celevac 500mg tablets

A methylcellulose product containing methylcellulose, registered in United Kingdom by Advanz Pharma. The same ATC class is registered in 2 of our 19 countries.

ATC A06AC06

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedCelevac 500mg tabletsATCA06AC06REGISTER NO.GB-APID-7970110000011…PACKS LISTED2CHECKEDSeptember 13, 2026

Where it is registered

Methylcellulose is registered in 2 of 19 countries.

Countries holding a registration under ATC A06AC06 (methylcellulose), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)

Methylcellulose · ATC A06AC06

2 / 19 countries

  • Japan
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Methylcellulose
Manufacturer
Advanz Pharma
Country
United Kingdom (GB)
ATC code
A06AC06
ATC class
Methylcellulose
Defined daily dose
2 g, O
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 2

  • gtin
    0502184000116
  • gtin
    5060064171639

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

29 interactions on record for methylcellulose.

Graded by severity as the source publishes them — 2 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Methylcellulose · interactions on record

29 records

  • 2 moderate
  • 27 minor

Most severe, free to view

  • LactuloseA06AD11moderate
  • Fludeoxyglucose (18F)V09IX04moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Methylcellulose in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All methylcellulose products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/6e26a7c2-0501-49a4-ab37-31a146c48665
GET /v1/drugs/6e26a7c2-0501-49a4-ab37-31a146c48665?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "797011000001102",
  "desc": "Celevac 500mg tablets (Advanz Pharma)",
  "form": "Oral tablet",
  "vpid": "42355511000001105",
  "source": "dmd",
  "vtm_id": "776743008",
  "strength": "500 mg",
  "substance": "Methylcellulose",
  "ingredient": "Methylcellulose 450",
  "supplier_code": "24129411000001106"
}

See everything about methylcellulose.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.